Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 4 minute read Pharma Industry News AbbVie to develop amylin analog for obesity treatment in $350m licensing deal with Gubra AbbVie has taken a significant step into obesity treatment through a licensing agreement with Denmark-based Gubra, a company… byPallavi MadhirajuMarch 3, 2025